Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Michael Böhm

Response to Letter Regarding Article, "Ambulatory Blood Pressure Changes After Renal Sympathetic Denervation in Patients With Resistant Hypertension"

Circulation
Cardiovascular MedicinePhysiologyCardiology
2014English

Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension: One-Year Results From the Symplicity HTN-2 Randomized, Controlled Trial

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

Effect of Ivabradine in Patients With Heart Failure With Preserved Ejection Fraction: The EDIFY Randomized Placebo-Controlled Trial

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Empagliflozin Reduces the Risk of a Broad Spectrum of Heart Failure Outcomes Regardless of Heart Failure Status at Baseline

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2019English

Influence of Atrial Fibrillation on Post-Discharge Natriuretic Peptide Trajectory and Clinical Outcomes Among Patients Hospitalized for Heart Failure: Insights From the ASTRONAUT Trial

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2016English

Evaluation of the Effect of Sodium–glucose Co‐transporter 2 Inhibition With Empagliflozin on Morbidity and Mortality of Patients With Chronic Heart Failure and a Reduced Ejection Fraction: Rationale for and Design of the EMPEROR‐Reduced Trial

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2019English

Heart Rate and Its Reduction in Chronic Heart Failure and Beyond

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Rationale and Design of the Multicentre, Randomized, Double-Blind, Placebo-Controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT)

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2011English

Expert Consensus Document From the European Society of Cardiology on Catheter-Based Renal Denervation

European Heart Journal
Cardiovascular MedicineCardiology
2013English

Evaluation of the Effects of Sodium–glucose Co‐transporter 2 Inhibition With Empagliflozin on Morbidity and Mortality in Patients With Chronic Heart Failure and a Preserved Ejection Fraction: Rationale for and Design of the EMPEROR‐Preserved Trial

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy